Abstract
This study was carried out to investigate early effects of parathyroidectomy (PTx) on bone matrix collagen metabolism. Eleven patients suffering from primary hyperparathyroidism were studied by measuring urinary excretion of hydroxyproline (OHPr) and cAMP in samples collected before PTx and, on the day of surgery, at intervals of 1–3 h for the first 10 h and then at longer intervals. In six patients nondialyzable urinary OHPr and free plasma aminoacid levels were also assayed. We found that the average period required for OHPr/Cr ratio and plasma OHPr to reach normal values was longer than the mean time required for cAMP/Cr ratio to reach normal limits. In all patients the total amount of nondialyzable OHPr decreased in the first 24 h after PTx but thereafter a daily increase in the urinary excretion of nondialyzable component was seen, so that the fractional amount of nondialyzable OHPr in the fourth postoperative day (26.8 ±5.2 SE) was significantly higher than that of preoperative one (6.1 ± 1.0; p < 0.02). Our results confirm that PTx induces a reduction in the rate of bone collagen resorption and indicate that changes of OHPr/Cr ratio and free plasma OHPr values may be considered useful indices of successful parathyroid surgery, even though they lag behind those of cAMP. The different behavior of total and nondialyzable OHPr after surgery indicates that acute deficiency of parathyroid hormone induces a positive uncoupling of the two processes of bone remodeling, thus supporting the view that the acute direct effect of the hormone on bone formation is an inhibition of this process.
Similar content being viewed by others
References
Parfitt A.M. The actions of parathyroid hormone on bone. Relation to bone remodeling and turnover, calcium homeostasis and metabolic bone disease. III. PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism. Metabolism 25: 1033, 1976.
Mallette L.E., Bilezikian J.P., Heath D.A, Aurbach G.D. Primary hyperparathyroidism: clinical and biochemical features. Medicine 53: 127, 1974.
Mazzuoli G.F., D’Erasmo E., Scarda A., S., Mancini D., Malaguti Aliberti L. Significance of early increase in stable and radioactive plasma calcium after parathyroidectomy in primary hyperparathyroidism. Calcif. Tissue Int. 29: 185, 1979.
Mazzuoli G.F., D’Erasmo E., Scarda A., Mancini D., Minisola S., Malaguti Aliberti L. Further studies on the significance of the early increase in serum calcium following parathyroidectomy in primary hyperparathyroidism. In: Mac Intyre I., Szelke M. (Eds.), Molecular endocrinology. Elsevier, North-Holland Biomedical Press, Amsterdam 1979, p. 327.
Muls E., Bouillon R., De Moor P. Hormonal and biochemical changes in patients successfully operated for primary hyperparathyroidism. Acta Endocrinol. (Kbh.) 83: 549, 1976.
Onishi T., Tsuji M., Morimoto S., Okada Y., Arima M., Itatani H., Kinoshita K., Sonoda T., Kumahara Y. Changes of urinary cyclic AMP excretion and plasma parathyroid hormone levels before and after parathyroidectomy in patients with primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 11: 307, 1979.
Spiegel A.M., Marx S.J., Brennan M.F., Brown E.M., Koehler J.O., Aurbach G.D. Urinary cAMP excretion during surgery: an index of successful parathyroidectomy in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 47: 537, 1978.
Spiegel A.M., Eastman S.T., Attie M.F., Downs R.W. Jr., Levine M.A., Marx S.J., Stock J.L., Saxe A.W., Brennan M.F., Aurbach G.D. Intraoperative measurements of urinary cyclic AMP to guide surgery for primary hyperparathyroidism. N. Engl. J. Med. 303: 1457; 1980.
Kalima T., Kivirikko K.I., Lattinen O., Uitto J. Urinary free and total hydroxyproline in hyperparathyroidism and the effect of removal of parathyroid adenoma. Clin. Chim. Acta 19: 443, 1968.
Smith R. Dissociation between changes in urinary total hydroxy-proline and plasma alkaline phosphatase after removal of parathyroid tumor. Clin. Chim. Acta 23: 421, 1969.
Haddad J.G. Jr., Couranz S., Avioli L.V. Non dialyzable urinary hydroxyproline as an index of bone collagen formation. J. Clin. Endocrinol. Metab. 30: 282, 1970.
Peacock M., Pierides A.M., Nordin B.E.C. Biochemical changes following parathyroidectomy. In: Endocrinology 1971. Proceedings of the third international Symposium. William Heinemann Medical Books Ltd, London, 1972, p. 350.
Parfitt A.M. The actions of parathyroid hormone on bone. Relation to bone remodeling and turnover, calcium homeostasis and metabolic bone disease. II. PTH and bone cells: bone turnover and plasma calcium regulation. Metabolism 25: 909, 1976.
Halse J., Gordeladze J.O. Urinary excretion of calcium, hydroxyproline and 3’, 5’-cyclic adenosine monophosphate in primary hyperparathyroidism. Acta Endocrinol. (Kbh.) 92: 138, 1979.
Hodgkinson A., Knowles C.F. Laboratory methods. In: Nordin B.E.C. (Ed.), Calcium phosphate and magnesium metabolism. Churchill Livingstone, London, 1976, p. 525.
Husdan H., Leung M., Oreopoulos D., Rapoport A. Measurement of free and free-plus peptide hydroxyproline fractions in plasma. Clin. Chem. 24: 204, 1978.
Krane S.M., Munoz A.J., Harris E.D. Urinary polypeptides related to collagen synthesis. J. Clin. Invest. 49: 716, 1970.
Broadus A.E., Mahaffey J.E., Bartter F.C., Neer R.M. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J. Clin. Invest. 60: 771, 1977.
Delmas P.D., Stenner D., Wahner H.W., Mann K.G., Riggs B.L Serum bone GLA protein increases with ageing in normal women: implications for age-related bone loss. 4th Annual Scientific Meeting of the American Society for Bone and Mineral Research, 1982 (Abstract).
Mazzuoli G.F., D’Erasmo E., Scarda A., Minisola S., Mancini D., Valtorta C, Tabolli S. Studies on parathyroid function in some pathophysiological conditions. In: Albertini A., Ekins R. (Eds.), Monoclonal antibodies and developments in immunoassay. Elsevier, North Holland Biomedical Press, Amsterdam, 1981, p. 231.
Lloyd H.M. Primary hyperparathyroidism: analysis of the role of the parathyroid tumor. Medicine 47: 53, 1968.
Parfitt A.M. Equilibrium and disequilibrium hypercalcemia. New light on an old concept. Metab. Bone Dis. Rel. Res. 1: 279, 1979.
Parthemore J.G., Deftos L.J. Calcitonin secretion in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 49: 223, 1979.
Mazzuoli G.F., D’Erasmo E., Scarda A., Mancini D., Mini-sola S., Malaguti Aliberti L., Valtorta C. Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism. Clin. Endocrinol. (Oxf.) 75: 81, 1981.
Stanbury S.W. Vitamin D and hyperparathyroidism. J. Res. Coll. Phys. Lond. 15: 205, 1981.
Lumb G.A, Stanbury S.W. Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. Am. J. Med. 56: 833, 1974.
Albright G., Reifenstein E.C., Jr. The parathyroid glands and metabolic bone disease. Williams and Wilkins, Baltimore, 1948, p. 104.
Krane S.M., Munoz A.S., Harris E.D. Collagen-like fragments: excretion in urine of patients with Paget’s disease of bone. Science 157: 713, 1967.
Kalu D.N. Evaluation of a new technique for measuring bone formation. Med. Lab. Technol. 32: 98, 1973.
Laitinen O. Clinical applications of urinary hydroxyproline determination. Acta Med. Scand. (Suppl.) 577: 26, 1974.
Laitinen O. Bone, calcium, and hydroxyproline metabolism in hyperparathyroidism and after removal of parathyroid adenoma. Acta Med. Scand. 202: 39, 1972.
Caniggia A., Gennari C., Guideri R., Cesari L. Comparison between the results of radiocalcium studies and histological findings in a case of primary hyperparathyroidism (osteitis fibrosa cystica generalisata of von Recklinghausen) before and after removal of parathyroid adenoma. J. Clin. Endocrinol. Metab. 26: 867, 1966.
Chesnut C.H. III, Ivey J.L., Nelp W.B., Baylink D.J. Assessment of anabolic steroids and calcitonin in the treatment of osteoporosis. In: Barzel U.S. (Ed.), Osteoporosis II. Grune & Stratton, New York, 1979, p. 135.
Baylink D., Farley J., Howar G., Drivdhal R., Puzas E., Masuda T., Ivey J., Gruber H. In: Massry S.G., Letteri J.M., Ritz F. (Eds.), Regulation of phosphate and mineral metabolism. Plenum Press, New York, 1981, p. 409.
Author information
Authors and Affiliations
Additional information
This work was supported by a grant from the Consiglio Nazionale delle Ricerche. The results of this study have been partly presented at the XIV Acta Endocrinologica Congress, June 1983, Stockholm, Sweden.
Rights and permissions
About this article
Cite this article
Minisola, S., Medori, C., Antonelli, R. et al. Acute effects of removal of parathyroid adenoma on plasma and urinary hydroxyproline levels. J Endocrinol Invest 7, 563–568 (1984). https://doi.org/10.1007/BF03349487
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349487